High levels of RAD51 perturb DNA replication elongation and cause unscheduled origin firing due to impaired CHK1 activation

References

• Arnaudeau C, Lundin C, Helleday T. DNA double-strand breaks associated with replication forks are predominantly repaired by homologous recombination involving an exchange mechanism in mammalian cells. J Mol Biol 2001; 307:1235-45; PMID:11292338; http://dx.doi.org/10.1006/jmbi.2001.4564
   PubMed Web of Science ®Google Scholar
• Llorente B, Smith CE, Symington LS. Break-induced replication: what is it and what is it for? Cell Cycle 2008; 7:859-64; PMID:18414031; http://dx.doi.org/10.4161/cc.7.7.5613
   PubMed Web of Science ®Google Scholar
• Petermann E, Orta ML, Issaeva N, Schultz N, Helleday T. Hydroxyurea-stalled replication forks become progressively inactivated and require two different RAD51-mediated pathways for restart and repair. Mol Cell 2010; 37:492-502; PMID:20188668; http://dx.doi.org/10.1016/j.molcel.2010.01.021
   PubMed Web of Science ®Google Scholar
• Burrell RA, McGranahan N, Bartek J, Swanton C. The causes and consequences of genetic heterogeneity in cancer evolution. Nature 2013; 501:338-45; PMID:24048066; http://dx.doi.org/10.1038/nature12625
   PubMed Web of Science ®Google Scholar
• Orr SJ, Gaymes T, Ladon D, Chronis C, Czepulkowski B, Wang R, Mufti GJ, Marcotte EM, Thomas NS. Reducing MCM levels in human primary T cells during the G(0)–>G(1) transition causes genomic instability during the first cell cycle. Oncogene 2010; 29:3803-14; PMID:20440261; http://dx.doi.org/10.1038/onc.2010.138
   PubMed Web of Science ®Google Scholar
• Aze A, Zhou JC, Costa A, Costanzo V. DNA replication and homologous recombination factors: acting together to maintain genome stability. Chromosoma 2013; 122:401-13; PMID:23584157; http://dx.doi.org/10.1007/s00412-013-0411-3
   PubMed Web of Science ®Google Scholar
• Helleday T, Lo J, van Gent DC, Engelward BP. DNA double-strand break repair: from mechanistic understanding to cancer treatment. DNA Repair 2007; 6:923-35; PMID:17363343; http://dx.doi.org/10.1016/j.dnarep.2007.02.006
   PubMed Web of Science ®Google Scholar
• Lim DS, Hasty P. A mutation in mouse rad51 results in an early embryonic lethal that is suppressed by a mutation in p53. Mol Cell Biol 1996; 16:7133-43; PMID:8943369
   PubMed Web of Science ®Google Scholar
• Sonoda E, Sasaki MS, Buerstedde JM, Bezzubova O, Shinohara A, Ogawa H, Takata M, Yamaguchi-Iwai Y, Takeda S. Rad51-deficient vertebrate cells accumulate chromosomal breaks prior to cell death. EMBO 1998; 17:598-608; http://dx.doi.org/10.1093/emboj/17.2.598
   PubMed Web of Science ®Google Scholar
• Vispe S, Cazaux C, Lesca C, Defais M. Overexpression of Rad51 protein stimulates homologous recombination and increases resistance of mammalian cells to ionizing radiation. Nucleic Acids Res 1998; 26:2859-64; PMID:9611228; http://dx.doi.org/10.1093/nar/26.12.2859
   PubMed Web of Science ®Google Scholar
• Koch K, Wrona A, Dikomey E, Borgmann K. Impact of homologous recombination on individual cellular radiosensitivity. Radiother Oncol 2009; 90:265-72; PMID:18804300; http://dx.doi.org/10.1016/j.radonc.2008.07.028
   PubMed Web of Science ®Google Scholar
• Raderschall E, Stout K, Freier S, Suckow V, Schweiger S, Haaf T. Elevated levels of Rad51 recombination protein in tumor cells. Cancer Res 2002; 62:219-25; PMID:11782381
   PubMed Web of Science ®Google Scholar
• Li Y, Yu H, Luo RZ, Zhang Y, Zhang MF, Wang X, Jia WH. Elevated expression of Rad51 is correlated with decreased survival in resectable esophageal squamous cell carcinoma. J Surg Oncol 2011; 104:617-22; PMID:21744352; http://dx.doi.org/10.1002/jso.22018
   PubMed Web of Science ®Google Scholar
• Tennstedt P, Fresow R, Simon R, Marx A, Terracciano L, Petersen C, Sauter G, Dikomey E, Borgmann K. RAD51 overexpression is a negative prognostic marker for colorectal adenocarcinoma. Int J Cancer 2013; 132:2118-26; PMID:23065657; http://dx.doi.org/10.1002/ijc.27907
   PubMed Web of Science ®Google Scholar
• Le Scodan R, Cizeron-Clairac G, Fourme E, Meseure D, Vacher S, Spyratos F, de la Lande B, Cvitkovic F, Lidereau R, Bieche I. DNA repair gene expression and risk of locoregional relapse in breast cancer patients. Int J Radiat Oncol Phys 2010; 78:328-36; http://dx.doi.org/10.1016/j.ijrobp.2009.07.1735
   PubMed Web of Science ®Google Scholar
• Kim PM, Allen C, Wagener BM, Shen Z, Nickoloff JA. Overexpression of human RAD51 and RAD52 reduces double-strand break-induced homologous recombination in mammalian cells. Nucleic Acids Res 2001; 29:4352-60; PMID:11691922; http://dx.doi.org/10.1093/nar/29.21.4352
   PubMed Web of Science ®Google Scholar
• Paffett KS, Clikeman JA, Palmer S, Nickoloff JA. Overexpression of Rad51 inhibits double-strand break-induced homologous recombination but does not affect gene conversion tract lengths. DNA Repair 2005; 4:687-98; PMID:15878310; http://dx.doi.org/10.1016/j.dnarep.2005.03.003
   PubMed Web of Science ®Google Scholar
• Yanez RJ, Porter AC. Differential effects of Rad52p overexpression on gene targeting and extrachromosomal homologous recombination in a human cell line. Nucleic Acids Res 2002; 30:740-8; PMID:11809887; http://dx.doi.org/10.1093/nar/30.3.740
   PubMed Web of Science ®Google Scholar
• Lambert S, Lopez BS. Characterization of mammalian RAD51 double strand break repair using non-lethal dominant-negative forms. EMBO 2000; 19:3090-9; http://dx.doi.org/10.1093/emboj/19.12.3090
   PubMed Web of Science ®Google Scholar
• Richardson C, Stark JM, Ommundsen M, Jasin M. Rad51 overexpression promotes alternative double-strand break repair pathways and genome instability. Oncogene 2004; 23:546-53; PMID:14724582; http://dx.doi.org/10.1038/sj.onc.1207098
   PubMed Web of Science ®Google Scholar
• Magwood AC, Mundia MM, Baker MD. High levels of wild-type BRCA2 suppress homologous recombination. J Mol Biol 2012; 421:38-53; PMID:22579622; http://dx.doi.org/10.1016/j.jmb.2012.05.007
   PubMed Web of Science ®Google Scholar
• Takata M, Sasaki MS, Tachiiri S, Fukushima T, Sonoda E, Schild D, Thompson LH, Takeda S. Chromosome instability and defective recombinational repair in knockout mutants of the five Rad51 paralogs. Mol Cell Biol 2001; 21:2858-66; PMID:11283264; http://dx.doi.org/10.1128/MCB.21.8.2858-2866.2001
   PubMed Web of Science ®Google Scholar
• Martin RW, Orelli BJ, Yamazoe M, Minn AJ, Takeda S, Bishop DK. RAD51 up-regulation bypasses BRCA1 function and is a common feature of BRCA1-deficient breast tumors. Cancer Res 2007; 67:9658-65; PMID:17942895; http://dx.doi.org/10.1158/0008-5472.CAN-07-0290
   PubMed Web of Science ®Google Scholar
• Lee SA, Roques C, Magwood AC, Masson JY, Baker MD. Recovery of deficient homologous recombination in Brca2-depleted mouse cells by wild-type Rad51 expression. DNA Repair 2009; 8:170-81; PMID:18992372; http://dx.doi.org/10.1016/j.dnarep.2008.10.002
   PubMed Web of Science ®Google Scholar
• Schild D, Wiese C. Overexpression of RAD51 suppresses recombination defects: a possible mechanism to reverse genomic instability. Nucleic Acids Res 2010; 38:1061-70; PMID:19942681; http://dx.doi.org/10.1093/nar/gkp1063
   PubMed Web of Science ®Google Scholar
• Schlacher K, Christ N, Siaud N, Egashira A, Wu H, Jasin M. Double-strand break repair-independent role for BRCA2 in blocking stalled replication fork degradation by MRE11. Cell 2011; 145:529-42; PMID:21565612; http://dx.doi.org/10.1016/j.cell.2011.03.041
   PubMed Web of Science ®Google Scholar
• Schlacher K, Wu H, Jasin M. A distinct replication fork protection pathway connects Fanconi anemia tumor suppressors to RAD51-BRCA1/2. Cancer Cell 2012; 22:106-16; PMID:22789542; http://dx.doi.org/10.1016/j.ccr.2012.05.015
   PubMed Web of Science ®Google Scholar
• Yata K, Bleuyard JY, Nakato R, Ralf C, Katou Y, Schwab RA, Niedzwiedz W, Shirahige K, Esashi F. BRCA2 coordinates the activities of cell-cycle kinases to promote genome stability. Cell Rep 2014; 7:1547-59; PMID:24835992; http://dx.doi.org/10.1016/j.celrep.2014.04.023
   PubMed Web of Science ®Google Scholar
• Hashimoto Y, Puddu F, Costanzo V. RAD51- and MRE11-dependent reassembly of uncoupled CMG helicase complex at collapsed replication forks. Nat Struct Mol Biol 2012; 19:17-24; http://dx.doi.org/10.1038/nsmb.2177
   PubMed Web of Science ®Google Scholar
• Hashimoto Y, Ray Chaudhuri A, Lopes M, Costanzo V. Rad51 protects nascent DNA from Mre11-dependent degradation and promotes continuous DNA synthesis. Nat Struc Mol Biol 2010; 17:1305-11; http://dx.doi.org/10.1038/nsmb.1927
   PubMed Web of Science ®Google Scholar
• Min W, Bruhn C, Grigaravicius P, Zhou ZW, Li F, Kruger A, Siddeek B, Greulich KO, Popp O, Meisezahl C, et al. Poly(ADP-ribose) binding to Chk1 at stalled replication forks is required for S-phase checkpoint activation. Nat Comm 2013; 4:2993
   PubMed Web of Science ®Google Scholar
• Cimprich KA, Cortez D. ATR: an essential regulator of genome integrity. Nat Rev 2008; 9:616-27; http://dx.doi.org/10.1038/nrm2450
   Google Scholar
• Feijoo C, Hall-Jackson C, Wu R, Jenkins D, Leitch J, Gilbert DM, Smythe C. Activation of mammalian Chk1 during DNA replication arrest: a role for Chk1 in the intra-S phase checkpoint monitoring replication origin firing. J Cell Biol 2001; 154:913-23; PMID:11535615; http://dx.doi.org/10.1083/jcb.200104099
   PubMed Web of Science ®Google Scholar
• Zou L, Elledge SJ. Sensing DNA damage through ATRIP recognition of RPA-ssDNA complexes. Science 2003; 300:1542-8; http://dx.doi.org/10.1126/science.1083430
   PubMed Web of Science ®Google Scholar
• Nam EA, Cortez D. ATR signalling: more than meeting at the fork. Biochem 2011; 436:527-36; http://dx.doi.org/10.1042/BJ20102162
   Web of Science ®Google Scholar
• Sokka M, Parkkinen S, Pospiech H, Syvaoja JE. Function of TopBP1 in genome stability. SubCell Biochem 2010; 50:119-41; PMID:20012580
   PubMedGoogle Scholar
• Smits VA, Reaper PM, Jackson SP. Rapid PIKK-dependent release of Chk1 from chromatin promotes the DNA-damage checkpoint response. Curr Biol 2006; 16:150-9; http://dx.doi.org/10.1016/j.cub.2005.11.066
   PubMed Web of Science ®Google Scholar
• Zhao H, Piwnica-Worms H. ATR-mediated checkpoint pathways regulate phosphorylation and activation of human Chk1. Mol Cell Biol 2001; 21:4129-39; PMID:11390642; http://dx.doi.org/10.1128/MCB.21.13.4129-4139.2001
   PubMed Web of Science ®Google Scholar
• Ge XQ, Blow JJ. Chk1 inhibits replication factory activation but allows dormant origin firing in existing factories. J Cell Biol 2010; 191:1285-97; PMID:21173116; http://dx.doi.org/10.1083/jcb.201007074
   PubMed Web of Science ®Google Scholar
• Syljuasen RG, Sorensen CS, Hansen LT, Fugger K, Lundin C, Johansson F, Helleday T, Sehested M, Lukas J, Bartek J. Inhibition of human Chk1 causes increased initiation of DNA replication, phosphorylation of ATR targets, and DNA breakage. Mol Cell Biol 2005; 25:3553-62; PMID:15831461; http://dx.doi.org/10.1128/MCB.25.9.3553-3562.2005
   PubMed Web of Science ®Google Scholar
• Petermann E, Maya-Mendoza A, Zachos G, Gillespie DA, Jackson DA, Caldecott KW. Chk1 requirement for high global rates of replication fork progression during normal vertebrate S phase. Mol Cell Biol 2006; 26:3319-26; PMID:16581803; http://dx.doi.org/10.1128/MCB.26.8.3319-3326.2006
   PubMed Web of Science ®Google Scholar
• Maya-Mendoza A, Petermann E, Gillespie DA, Caldecott KW, Jackson DA. Chk1 regulates the density of active replication origins during the vertebrate S phase. EMBO 2007; 26:2719-31; http://dx.doi.org/10.1038/sj.emboj.7601714
   PubMed Web of Science ®Google Scholar
• Sorensen CS, Hansen LT, Dziegielewski J, Syljuasen RG, Lundin C, Bartek J, Helleday T. The cell-cycle checkpoint kinase Chk1 is required for mammalian homologous recombination repair. Nat Cell Biol 2005; 7:195-201; PMID:15665856; http://dx.doi.org/10.1038/ncb1212
   PubMed Web of Science ®Google Scholar
• Bahassi EM, Ovesen JL, Riesenberg AL, Bernstein WZ, Hasty PE, Stambrook PJ. The checkpoint kinases Chk1 and Chk2 regulate the functional associations between hBRCA2 and Rad51 in response to DNA damage. Oncogene 2008; 27:3977-85; PMID:18317453; http://dx.doi.org/10.1038/onc.2008.17
   PubMed Web of Science ®Google Scholar
• Nikkila J, Parplys AC, Pylkas K, Bose M, Huo Y, Borgmann K, Rapakko K, Nieminen P, Xia B, Pospiech H, et al. Heterozygous mutations in PALB2 cause DNA replication and damage response defects. Nat Comm 2013; 4:2578; http://dx.doi.org/10.1038/ncomms3578
   PubMed Web of Science ®Google Scholar
• Bindra RS, Schaffer PJ, Meng A, Woo J, Maseide K, Roth ME, Lizardi P, Hedley DW, Bristow RG, Glazer PM. Down-regulation of Rad51 and decreased homologous recombination in hypoxic cancer cells. Mol Cell Biol 2004; 24:8504-18; PMID:15367671; http://dx.doi.org/10.1128/MCB.24.19.8504-8518.2004
   PubMed Web of Science ®Google Scholar
• Mukherjee A, Karmakar P. Attenuation of PTEN perturbs genomic stability via activation of Akt and down-regulation of Rad51 in human embryonic kidney cells. Mol Carcinogen 2013; 52:611-8; http://dx.doi.org/10.1002/mc.21903
   PubMed Web of Science ®Google Scholar
• Wang Y, Huang JW, Calses P, Kemp CJ, Taniguchi T. MiR-96 downregulates REV1 and RAD51 to promote cellular sensitivity to cisplatin and PARP inhibition. Cancer Res 2012; 72:4037-46; PMID:22761336; http://dx.doi.org/10.1158/0008-5472.CAN-12-0103
   PubMed Web of Science ®Google Scholar
• Gasparini P, Lovat F, Fassan M, Casadei L, Cascione L, Jacob NK, Carasi S, Palmieri D, Costinean S, Shapiro CL, et al. Protective role of miR-155 in breast cancer through RAD51 targeting impairs homologous recombination after irradiation. P Natl Acad Sci USA 2014; 111:4536-41; http://dx.doi.org/10.1073/pnas.1402604111
   PubMed Web of Science ®Google Scholar
• Mansour WY, Schumacher S, Rosskopf R, Rhein T, Schmidt-Petersen F, Gatzemeier F, Haag F, Borgmann K, Willers H, Dahm-Daphi J. Hierarchy of nonhomologous end-joining, single-strand annealing and gene conversion at site-directed DNA double-strand breaks. Nucleic Res 2008; 36:4088-98; http://dx.doi.org/10.1093/nar/gkn347
   PubMed Web of Science ®Google Scholar
• Deans AJ, West SC. DNA interstrand crosslink repair and cancer. Nat Rev Cancer 2011; 11:467-80; PMID:21701511; http://dx.doi.org/10.1038/nrc3088
   PubMed Web of Science ®Google Scholar
• Garcia-Higuera I, Taniguchi T, Ganesan S, Meyn MS, Timmers C, Hejna J, Grompe M, D'Andrea AD. Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. Mol Cell 2001; 7:249-62; PMID:11239454; http://dx.doi.org/10.1016/S1097-2765(01)00173-3
   PubMed Web of Science ®Google Scholar
• Zhong Y, Nellimoottil T, Peace JM, Knott SR, Villwock SK, Yee JM, Jancuska JM, Rege S, Tecklenburg M, Sclafani RA, et al. The level of origin firing inversely affects the rate of replication fork progression. J Cell Biol 2013; 201:373-83; PMID:23629964; http://dx.doi.org/10.1083/jcb.201208060
   PubMed Web of Science ®Google Scholar
• Conti C, Seiler JA, Pommier Y. The mammalian DNA replication elongation checkpoint: implication of Chk1 and relationship with origin firing as determined by single DNA molecule and single cell analyses. Cell Cycle 2007; 6:2760-7; PMID:17986860; http://dx.doi.org/10.4161/cc.6.22.4932
   PubMed Web of Science ®Google Scholar
• Krejci L, Altmannova V, Spirek M, Zhao X. Homologous recombination and its regulation. Nucleic acids Res 2012; 40:5795-818; PMID:22467216; http://dx.doi.org/10.1093/nar/gks270
   PubMed Web of Science ®Google Scholar
• Mason JM, Dusad K, Wright WD, Grubb J, Budke B, Heyer WD, Connell PP, Weichselbaum RR, Bishop DK. RAD54 family translocases counter genotoxic effects of RAD51 in human tumor cells. Nucleic acids Res 2015; 43:3180-96; PMID:25765654; http://dx.doi.org/10.1093/nar/gkv175
   PubMed Web of Science ®Google Scholar
• Lundin C, Schultz N, Arnaudeau C, Mohindra A, Hansen LT, Helleday T. RAD51 is involved in repair of damage associated with DNA replication in mammalian cells. J Mol Biol 2003; 328:521-35; PMID:12706714; http://dx.doi.org/10.1016/S0022-2836(03)00313-9
   PubMed Web of Science ®Google Scholar
• Budzowska M, Kanaar R. Mechanisms of dealing with DNA damage-induced replication problems. Cell Biochem Biophys 2009; 53:17-31; PMID:19034694; http://dx.doi.org/10.1007/s12013-008-9039-y
   PubMed Web of Science ®Google Scholar
• Petermann E, Helleday T. Pathways of mammalian replication fork restart. Nat Rev 2010; 11:683-7; http://dx.doi.org/10.1038/nrm2974
   Google Scholar
• Daboussi F, Thacker J, Lopez BS. Genetic interactions between RAD51 and its paralogues for centrosome fragmentation and ploidy control, independently of the sensitivity to genotoxic stresses. Oncogene 2005; 24:3691-6; PMID:15782136; http://dx.doi.org/10.1038/sj.onc.1208438
   PubMed Web of Science ®Google Scholar
• Pefani DE, O'Neill E. Safeguarding Genome stability: RASSF1A tumour suppressor regulates BRCA2 at stalled forks. Cell Cycle 2015:0; [Epub ahead of print]; PMID:25927241
   PubMed Web of Science ®Google Scholar
• Wang X, Kennedy RD, Ray K, Stuckert P, Ellenberger T, D'Andrea AD. Chk1-mediated phosphorylation of FANCE is required for the Fanconi anemia/BRCA pathway. Mol Cell Biol 2007; 27:3098-108; PMID:17296736; http://dx.doi.org/10.1128/MCB.02357-06
   PubMed Web of Science ®Google Scholar
• Lossaint G, Besnard E, Fisher D, Piette J, Dulic V. Chk1 is dispensable for G2 arrest in response to sustained DNA damage when the ATM/p53/p21 pathway is functional. Oncogene 2011; 30:4261-74; PMID:21532626; http://dx.doi.org/10.1038/onc.2011.135
   PubMed Web of Science ®Google Scholar
• Collis SJ, Ciccia A, Deans AJ, Horejsi Z, Martin JS, Maslen SL, Skehel JM, Elledge SJ, West SC, Boulton SJ. FANCM and FAAP24 function in ATR-mediated checkpoint signaling independently of the Fanconi anemia core complex. Mol Cell 2008; 32:313-24; PMID:18995830; http://dx.doi.org/10.1016/j.molcel.2008.10.014
   PubMed Web of Science ®Google Scholar
• Guervilly JH, Mace-Aime G, Rosselli F. Loss of CHK1 function impedes DNA damage-induced FANCD2 monoubiquitination but normalizes the abnormal G2 arrest in Fanconi anemia. Hum Mol Genet 2008; 17:679-89; PMID:18029388; http://dx.doi.org/10.1093/hmg/ddm340
   PubMed Web of Science ®Google Scholar
• Hansen LT, Lundin C, Helleday T, Poulsen HS, Sorensen CS, Petersen LN, Spang-Thomsen M. DNA repair rate and etoposide (VP16) resistance of tumor cell subpopulations derived from a single human small cell lung cancer. Lung Cancer 2003; 40:157-64; PMID:12711116; http://dx.doi.org/10.1016/S0169-5002(03)00026-6
   PubMed Web of Science ®Google Scholar
• Slupianek A, Schmutte C, Tombline G, Nieborowska-Skorska M, Hoser G, Nowicki MO, Pierce AJ, Fishel R, Skorski T. BCR/ABL regulates mammalian RecA homologs, resulting in drug resistance. Mol Cell 2001; 8:795-806; PMID:11684015; http://dx.doi.org/10.1016/S1097-2765(01)00357-4
   PubMed Web of Science ®Google Scholar
• Chu WK, Hickson ID. RecQ helicases: multifunctional genome caretakers. Nat Rev Cancer 2009; 9:644-54; PMID:19657341; http://dx.doi.org/10.1038/nrc2682
   PubMed Web of Science ®Google Scholar
• Maacke H, Jost K, Opitz S, Miska S, Yuan Y, Hasselbach L, Luttges J, Kalthoff H, Sturzbecher HW. DNA repair and recombination factor Rad51 is over-expressed in human pancreatic adenocarcinoma. Oncogene 2000; 19:2791-5; PMID:10851081; http://dx.doi.org/10.1038/sj.onc.1203578
   PubMed Web of Science ®Google Scholar